The SURMOUNT-4 Evidence The SURMOUNT-4 trial, published in JAMA in 2024 by Aronne et al., was specifically designed to answer the maintenance question
doi: 10.1016/j.vetimm.2016.01.003 191 WalkerR
Underlying action mechanism of a novel antioxidant peptide derived from Allium tuberosum Rottler protein hydrolysates and its protective effects on hydrogen peroxide induced cell injury
$25.95 Buck Mountain Botanicals Bugleweed Buck Mountain Botanicals Bugleweed contains bugleweed extract and can be useful for animals with mild over-active thyroid conditions
Do not use if the solution contains particles, is cloudy, or colored
While 1544% of patients experience gastrointestinal symptoms like nausea, these typically represent expected pharmacologic effects rather than true gastroparesis, which requires objective confirmation through gastric emptying studies